Novel NASH Ex vivo Model using Hepatic Organoids Connected to Bile Ducts (HBTO)

Peptide drug for fibrosis

Designed RANKL fragment peptides (Partial agonist of RANKL) treat fibrosis.

A new concept for the treatment of allergic dermatitis by targeting glycan receptors on macrophages

Inhibition of TLR4-dependent allergic inflammatory response by Asialoglycoprotein receptor (Asgr1) glycan ligands

Liver organoid model containing human hepatocytes for pharmacokinetic assay

Original method and hepatocyte reproduced hepatobiliary function

Neuro-protectant Peptides for Ischemic Stroke

Fragmentation of RANKL Eliminates Side-effect while Boosting Effect.